Other Nonbiological Approaches to Targeted Cancer Chemotherapy
- 19 June 2015
- book chapter
- book charpter
- Published by Elsevier BV
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism studyThe Lancet Oncology, 2012
- Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated ActivationAngewandte Chemie, 2012
- Proteasome Inhibitors: An Expanding Army Attacking a Unique TargetCell Chemical Biology, 2012
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemiaBlood Reviews, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle DamageCancer Cell, 2010
- Disrupting protein–protein interactions with non-peptidic, small molecule α-helix mimeticsCurrent Opinion in Chemical Biology, 2010
- New developments in the discovery of small molecule Hedgehog pathway antagonistsCurrent Opinion in Chemical Biology, 2010
- Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In SituMolecular Cell, 2010
- Evidence that Mitotic Exit Is a Better Cancer Therapeutic Target Than Spindle AssemblyCancer Cell, 2009